Ropes & Gray represented Genesis Therapeutics in the transaction. Genesis Therapeutics completed a $52 million Series A financing round to accelerate artificial intelligence innovation and to…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now